age1 — 2026 Investments

3 investments dated 2026 · listed companies and verified rows first · show all

Aerskaaerska.com inFeb 2026 · $39M

Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.

BiotechDeep TechHealthtechMedical Devices

Stuart Milstein(Chief Platform Officer, Co-founder)inJack O’Meara(Chief Executive Officer, Co-founder)inDave Hardwicke(Director, Head of Business Development, Co-founder)

Co-investorsBacked BlueYard Capital Entrepreneur First Global Health Investment Corporation Iaso Ventures Lingotto +6 more

Longevity Fundlongevity.vcFeb 2026 · $100M

A venture capital firm focused on the longevity sector, backing founder-driven companies working on extending human healthy lifespan.

BiotechLongevity

Laura Deming(Founder)inAlex Colville(General Partner)in

Co-investors1517 Collaborative Fund

Loyalloyal.com in 𝕏Feb 2026 · $100M

Loyal develops longevity drugs for dogs, targeting the biological processes of aging to extend healthy lifespan and reduce age-associated disease.

BiotechHealthtechLongevity

Celine Halioua(Founder)in

Co-investorsBain Capital Ventures BoxGroup Collaborative Fund First Round Capital Flucas Ventures Gaingels +18 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.